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INTRODUCTION
STUDY AIMS
The purpose of this study is to verify the efficacy of TruScient® in healing and bone formation by analyzing different complicated orthopedic cases from the Hospital Clí-
nic Veterinari of the UAB in which it was used.
MATERIALS & METHODS 
Case Species Breed Age Sex Weight (Kg) Surgery reason Surgical treatment
BMP 
extremity Evolution Complications
Consolidation 
time (months)
1 Feline European Shorthair 2 years F 3,5 Femoral fx Osteosynthesis plate, 7 screws, 2 cer-clages and BMP. RPE Favorable Yes
1,2 2
2 Canine Miniature Pinscher 8 months M 5,14 Bilateral fx of ulna/radius Osteosynthesis plate, 6 screws and BMP. RAE Favorable No 1,5
3 Feline European Shorthair 1 year CM 4,5 Humerus fx Tie-in, 3 cerclages, 1 screw and BMP. LAE Favorable No 1,5
4 Canine Siberian Husky 6 years CF 21 Palmar fibrocartilague fx. Carpal arthrodesis Hybrid arthrodesis plate and BMP. RAE Favorable Yes
3,4 3,5
5 Feline European Shorthair 1 year CF 2,8 Humerus + left femoral neck fx Tie-in, 2 cerclages, 1 screw and BMP. RAE Favorable Yes3 1
6 Feline European Shorthair 1 year M 4 P/O bone sequestrum on tibia Bone curettage and BMP. LPE Favorable Yes4 2
7 Canine Mixed breed 7 years F 6,6 Bilateral femur fx Osteosynthesis plate, 9 screws and BMP. RPE Favorable No 3
8 Canine Yorkshire Terrier 1 year M 3,4 Not union of radius Synthetic Robocasted graft and BMP. LAE Favorable Yes5.1 3
9 Canine Bullmastiff 3 years M 51,2 Palmar fibrocartilague fx.Carpal arthrodesis
Braun Orthomed double metacarpal 
plate and BMP. RAE Favorable Yes
6 4
10 Feline European Shorthair 13 years CM 4 Humerus fx Intramedullary nail, 2 screws, 1 cercla-ge and BMP. LAE Slow Yes
7 4
11 Canine Pointer 6 years M 27,5 Revision of tibia fx.Leish +
DCP plate, 8 screws, cancellous bone 
and BMP. LPE Slow Yes
7 5
12 Canine Labrador Retriever 8 years M 26,8 Revision of arthrodesis. Leish +
External fixator, 2 Kirschner needles 
and BMP. RAE Slow Yes
4,7,8,9 10,5
13 Canine German Shepherd 9 months F 24,5 Femoral fx revision. 1. Locked nail, 4 screws and BMP/ 2.Mo-dified external fixator, 2 screws and BMP. LPE Unfavorable Yes
3,4,5.2,8 -
Table 1. Details of the clinical cases used in the study.
F- Female; M - Male; CF- Castrated Female; CM- Castrated Male; Fx- fracture; RAE- Right anterior extremity; LAE- Left anterior extremity; RPE- Right posterior extremity; LPE- Left posterior estremity; 1- Pain; 2- Mus-
cular Atrophy; 3- No limb support; 4- Initial non-union; 5- Ankylosis (5.1- Carpal; 5.2- Knee); 6- Pacing, head tilt, lameness; 7- Slow consolidation; 8- Implant migration; 9- Osteolysis.
Since the discovery of bone morphogenetic proteins (BMP), it has come a long way in its identification and applications in traumatology. These are po-
tent growth factors of the TGF-β superfamily synthesized primarily by osteoblasts. Currently there are more than 20 subtypes, among which BMP-2 stands 
out for its high osteoinductive capacity. With the advancement of molecular techniques it has been possible to purify human recombinant BMP 2 (rhBMP-2), a 
substance that simulates BMPs, and is marketed as TruScient® in order to stimulate bone consolidation in cases with delayed bone healing or non-unions.
RESULTS DISCUSSION
A B C D E
   Figure 2. Example of evolution after rhBMP-2 addition (case 2). A. Pre-operative ra- 
  diography of a right ulna/radius fracture. B. Radiography 0 days post-operative. C. Ra-
  diography 7 days post-operative. D. Radiography 30 days post-operative. E. Radiogra-
  phy 50 days post-operative.
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CONCLUSION
Individual details of the 13 clinical cases that were part of the study are displayed in Table 1.
Figure 1. Evolution of bone healing
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Despite its recent withdrawal from the market for commercial reasons, rhBMP-2 
has been shown to be a very potent and effective osteoinductive factor in animals 
with delayed bone formation or non-union processes, in which its application redu-
ces the time of radiographic union.
The criterion to assess the evolution of the study 
cases was the time of consolidation, based on the 
time of radiographic union. The results concerning 
to the evolution of bone formation are shown in 
Figure 1. We can see as an example, the Figure 
2, that shows the evolution of case 2.  
The mean time of consolidation of the 13 cases was 
3.41 months and the success rate was 92.31%, 
considering only 1 of the cases as failure. In addi-
tion, a 76.92% of the animals showed a series of 
postoperative complications, that can be seen in 
detail in Table 1.
In most of the study cases, the use of rhBMP resulted in an early bone healing. 
The results obtained were similar to those of other studies such as the one carried 
out by Faria et al. (2007) with open tibial fractures.
The effect of rhBMP-2 depends on the vehicle used, the amount, the concentra-
tion and the time of application, as well as the presence of enough mesenchymal 
cells capable of responding to BMP.
Most of the cases had no complications, or were minor. Lameness and mild inflam-
mation are common in the first 3 weeks after implantation, but severe effects such 
as an excessive bone formation or the stimulation of malignant tumors are rare.
It has been seen in several studies and in the case 6, that even with osteomyeli-
tis, the BMP remains efficient. However, diseases such as Leishmania could mask 
their effects by slowing down the bone formation, as happened in cases 11 and 12.
The main limitations of the study were the lack of a common criterion of choice of 
the cases, apart from the severity of their injuries, as well as the lack of a control 
group with which to compare results.
